Skip to main content
. 2023 Oct 26;13:1273378. doi: 10.3389/fonc.2023.1273378

Table 2.

Results of the meta-analysis.

Outcomes No. of
studies
Sample size Heterogeneity Overall effect
size
95% CI of
overall effect
P Value
R L I2(%) P Value
Operation time (min) 9 1384 1382 95 <0.00001 WMD=5.19 18.00,39.82 <0.00001
Length of stay (days) 9 1247 1249 95 <0.00001 WMD=2.97 -1.60,–0.33 0.003
Conversion 10 1590 1583 0 0.63 RR=3.62 0.40,0.76 0.0003
Complications 11 1418 1413 26 0.21 RR=3.31 0.64,0.89 0.0009
CRM+ 6 1120 1105 0 0.81 RR=1.94 0.49,1.00 0.05
Proximal resection margin(cm) 7 1082 1084 95 <0.00001 WMD=-1.14 -1.16,0.31 0.25
Distal resection margin(cm) 6 908 911 92 <0.00001 WMD=2.16 0.04,0.94 <0.00001
Blood loss(ml) 7 1098 1098 97 <0.00001 WMD=2.71 -33.24,-5.35 0.007
The number of harvested lymph nodes 9 1391 1389 79 <0.00001 WMD=1.70 -0.09,1.31 0.09
The time of first flatus(days) 7 996 1004 99 <0.00001 WMD=0.88 -0.59,0.23 0.38
The time of first autonomous urination(days) 4 853 850 99 <0.00001 WMD=1.59 -2.01,0.21 0.11
The time of first defecation(days) 2 652 658 64 0.10 WMD=1.44 -0.80,0.12 0.15
The time of first resume diet(days) 6 975 980 97 <0.00001 WMD=1.77 -0.82,0.04 0.08
Reoperation rates 4 816 817 0 0.96 RR=2.12 0.33,0.96 0.03
Readmission rates 4 816 817 4 0.37 RR=1.45 0.41,1.14 0.15
Death rates 5 1083 1080 0 0.91 RR=0.97 0.24,1.62 0.33
Quality of TME:Complete 8 1356 1354 5 0.39 RR=2.76 1.01,1.08 0.006
Quality of TME:Incomplete 8 1356 1354 55 0.03 RR=2.53 0.67,0.95 0.01